Abstract
OBJECTIVE
To describe a rare case of occult (<1cm in diameter) medullary thyroid carcinoma (MTC) in a 45-year-old woman, presenting as an asymptomatic mediastinal mass.
DESIGN
The diagnostic methodology included laboratory measurements of relevant biochemical and hormonal parameters including calcitonin (CT), carcinoembryonic antigen (CEA) and chromogranin A, and imaging techniques including ultrasound (U/S), computed tomography (C/T), magnetic resonance imaging (MRI) and radio labeled somatostatin analog (111In-DTPA-octreotide).
RESULTS
Chest CT revealed a mediastinal mass measuring 5cm in diameter abutting the right thyroid lobe. CEA was elevated and an association with thyroid malignancies was considered. CT was found to be markedly elevated, pointing to the diagnosis of MTC metastatic to the mediastinum. The patient underwent total thyroidectomy, lymph node dissection and removal of the mediastinal mass. Histological examination revealed MTC of the right thyroid lobe measuring 0.5 cm, metastatic to regional and superior mediastinal lymph nodes.
CONCLUSIONS
Occult MTC can infrequently present as an asymptomatic mediastinal mass. Elevated serum CT and CEA along with imaging techniques leads to the correct diagnosis and surgical management of the disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lombardo F, Baudin E, Chiefari E, et al, 2002 Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804. J Clin Endocrinol Metab 87: 1674–1680.
Russell CF, Van Heerden JA, Sizemore GW, et al, 1983 The surgical management of medullary thyroid carcinoma. Ann Surg 197: 42–84.
Fleming JB, Lee JE, Bouvet M, et al, 1999 Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 230: 697–707.
Toledo S, Lourenço D, Santos MA, et al, 2009 Hypercalcitoninemia is not Pathognomonic of Medullary Thyroid Carcinoma. Clinics (Sao Paulo) 64: 699–706.
Costante G, Meringolo D, Durante C, et al, 2007 Predictive Value of Serum Calcitonin Levels for Preoperative Diagnosis of Medullary Thyroid Carcinoma in a Cohort of 5817 Consecutive Patients with Thyroid Nodules. J Clin Endocrinol Metab 92: 450–455.
Sakorafas G, Friess H, Peros G, 2008 The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy. Endocrine-Related Cancer 15: 871–884.
Gharib H, McConahey WM, Tiegs RD, et al, 1992 Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc 67: 934–940.
Kebebew E, Ituarte PH, Siperstein AE, et al, 2000 Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88: 1139–1148.
Costante G, Durante C, Francis Z, et al, 2009 Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls. Nat Clin Pract Endocrinol Metab 5: 35–44.
Kaltsas G, Besser M, Grossman A, 2004 The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors. Endocrine Rev 25: 458–511.
Klöppel G, Rindi G, Anlauf M, et al, 2007 Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors Virchows Arch 451: Suppl 1: S9–S27.
Hennessy JF, Wells Jr SA, Ontjes DA, et al, 1974 A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary carcinoma of the thyroid. J Clin Endocrinol Metab 39: 487–495.
Karges W, Dralle H, Raue F, et al, 2004 Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112: 52–58.
Cooper DS, Doherty GM, Haugen BR, et al, 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16: 109–142.
Lamberts SW, Hofland LJ, Nobels FR, 2001 Neuroendocrine tumor markers. Front Neuroendocrinol 22: 309–339.
Nobels FR, Kwekkeboom DJ, Coopmans W, et al, 1997 Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the α- subunit of glycoprotein hormones. J Clin Endocrinol Metab 82: 2622–2628.
Bümming P, Ahlman H, Nilsson B, et al, 2008 Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma? Langenbecks Arch Surg 393: 699–703.
Thomas SN, Tong Z, Stebe KJ, et al, 2009 Identification, characterization and utilization of tumor cell selectin ligands in the design of colon cancer diagnostics. Biorheology 46: 207–225.
Konstantopoulos K, Thomas SN, 2009 Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng 11: 177–202.
Thomas SN, Zhu F, Schnaar RL, et al, 2008 Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem 283: 15647–15655.
Kini S, Saraf CK, Naik LP, et al, 2008 Occult medullary carcinoma with lymph node metastases: a case report. Acta Cytol 52: 105–108.
Sironi M, Cozzi L, Pareschi R, et al, 1999 Occult sporadic medullary microcarcinoma with lymph node metastases. Diagn Cytopathol 21: 203–206.
Moley JF, DeBenedetti MK, 1999 Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229: 880–888.
Scollo C, Baudin E, Travagli JP, et al, 2003 Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88: 2070–2075.
Giraudet AL, Vanel D, Leboulleux S, et al, 2007 Imaging Medullary Thyroid Carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab 92: 4185–4190.
Pacini F, Castagna MG, Cipri C, et al, 2010 Medullary thyroid carcinoma. Clin Oncol (R Coll Radiol) 22: 475–485.
Kloos RT, Eng C, Evans DB, et al, 2009 Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19: 565–612.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Daraki, V., Koukouraki, S., Velegrakis, G. et al. Rare presentation of occult medullary carcinoma of the thyroid as a mediastinal mass. Hormones 11, 210–214 (2012). https://doi.org/10.14310/horm.2002.1350
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1350